Suggestions
Rebecca Lescarbeau, PhD
Associate Director at Intellia Therapeutics, Inc.
Rebecca Lescarbeau, PhD, is currently the Associate Director of Pre-Clinical Development at Intellia Therapeutics, Inc., based in Cambridge, Massachusetts. She has a strong background in biotechnology and has previously worked at Dicerna Pharmaceuticals as a principal scientist. Lescarbeau earned her Bachelor of Science in Biological Engineering from the Massachusetts Institute of Technology (MIT) in 2009 and completed her PhD in 2015 from the same institution.123
In her role at Intellia, she is involved in developing innovative CRISPR-based therapies aimed at treating various serious conditions, including cancer and genetic disorders. Lescarbeau has built a professional network of over 443 connections on LinkedIn, reflecting her active engagement in the biotechnology community.12
